California Neurodegenerative Disease Registry (CNDR): Multiple sclerosis

Starting on July 1, 2023, Health and Safety Code Section 103871 requires hospital, facility, physician and surgeon, and other health care providers to report to California Department of Public Health (CDPH) each case of a neurodegenerative disease that was designated as reportable by CDPH. However, in light of needed initial onboarding to the reporting systems and corresponding logistics, CDPH will be flexible with the reporting due dates for the first reporting period and will assist providers with the process.
All Hospitals, facilitys, physicians and surgeons, or other health care providers diagnosing or providing treatment for a patient with a neurodegenerative disease such as Multiple sclerosis (MS) must review the CNDR Electronic Neurodegenerative Disease Reporting Standards Implementation Guide (PDF).* 

MS is a disease of the central nervous system. In MS, the body’s immune system attacks myelin, which coat nerve cells. Symptoms include muscle weakness (often in the hands and legs), tingling and burning sensations, numbness, chronic pain, coordination and balance problems, fatigue, vision problems, cognitive changes and difficulty with bladder control. People with MS may feel depressed and have trouble thinking clearly. Although there is no cure, some conventional treatments can improve symptoms, reduce the number and severity of relapses, and delay the disease’s progression.**

*CNDR Electronic Neurodegenerative Disease Reporting Standards Implementation Guide (PDF)​.